Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 11687189)

Published in Cochrane Database Syst Rev on January 01, 2001

Authors

G Y Lip1, C R Gibbs

Author Affiliations

1: Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Dudley Road, Birmingham, UK, B18 7QH. g.y.h.lip@bham.ac.uk

Articles by these authors

Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol (1999) 1.88

ABC of heart failure. Clinical features and complications. BMJ (2000) 1.11

Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM (2002) 1.10

Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. QJM (2002) 1.08

ABC of heart failure. Pathophysiology. BMJ (2000) 0.97

ABC of heart failure. BMJ (2000) 0.88

Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure. Eur J Clin Invest (2003) 0.85

ABC of heart failure. Acute and chronic management strategies. BMJ (2000) 0.84

ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates. BMJ (2000) 0.82

Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation. Clin Cardiol (2001) 0.82

Atrial fibrillation and ethnicity. Circulation (1999) 0.79

Anticoagulation for heart failure in sinus rhythm. Cochrane Database Syst Rev (2001) 0.78

The clinical value of ambulatory blood pressure monitoring. Heart (1998) 0.77

ABC of heart failure: aetiology. BMJ (2000) 0.77

Antithrombotics for left-ventricular impairment. Lancet (1998) 0.75

Ambulatory blood pressure monitoring and stroke: more questions than answers. Stroke (1998) 0.75

Ethnicity and heart failure. Eur Heart J (1999) 0.75

Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes. Scott Med J (1998) 0.75